[{"NetIncomeLossConverted_4_FY_USD":-618695000.0,"NetIncomeLossConverted_1_FY_USD":-199874000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":-470351000.0,"CommonStockSharesOutstanding_0_FY_shares":66432000.0,"StockholdersEquity_0_FY_USD":1355056000.0,"EarningsPerShareBasic_1_FY_USD":-3.01,"EarningsPerShareBasic_4_FY_USD":-9.95,"Assets_0_FY_USD":1781252000.0,"CommonStockSharesConverted_0_FY_shares":66432000.0,"RevenuesConverted_1_FY_USD":10708000.0,"RevenuesConverted_4_FY_USD":250734000.0,"Ticker":"BLUE","CIK":"1293971","name":"BLUEBIRD BIO, INC.","OfficialName":"bluebird bio Inc. Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"4","uom":"USD","footnote":"nan","Market Cap":"301448421.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210223"}]